230 related articles for article (PubMed ID: 1637881)
21. [Megakaryopoiesis in chronic myeloproliferative disorders].
Nagasawa T
Rinsho Ketsueki; 1993 May; 34(5):551-6. PubMed ID: 8315826
[TBL] [Abstract][Full Text] [Related]
22. [Megakaryocytopoiesis in myeloproliferative disorders].
Podolak-Dawidziak M
Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
[No Abstract] [Full Text] [Related]
23. Analysis of megakaryocyte ploidy in patients with thrombocytosis.
Kanz L; Hollen C; Friese P; Burstein SA
Int J Cell Cloning; 1990 Jul; 8(4):299-306. PubMed ID: 2401806
[TBL] [Abstract][Full Text] [Related]
24. WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders.
Michiels JJ; De Raeve H; Hebeda K; Lam KH; Berneman Z; Schroyens W; Schwarz J
Leuk Res; 2007 Aug; 31(8):1031-8. PubMed ID: 17367853
[TBL] [Abstract][Full Text] [Related]
25. Bone marrow histopathology in myeloproliferative disorders--current diagnostic approach.
Thiele J; Kvasnicka HM; Orazi A
Semin Hematol; 2005 Oct; 42(4):184-95. PubMed ID: 16210032
[TBL] [Abstract][Full Text] [Related]
26. Density distribution and size of megakaryocytes in inflammatory reactions of the bone marrow (myelitis) and chronic myeloproliferative diseases.
Thiele J; Holgado S; Choritz H; Georgii A
Scand J Haematol; 1983 Oct; 31(4):329-41. PubMed ID: 6578591
[TBL] [Abstract][Full Text] [Related]
27. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
Macavei I; Galatâr N
Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
[TBL] [Abstract][Full Text] [Related]
28. Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients.
Thiele J; Kvasnicka HM
Ann Hematol; 2003 Mar; 82(3):148-52. PubMed ID: 12634946
[TBL] [Abstract][Full Text] [Related]
29. [Megakaryocytic myelosis--cause of "idiopathic" thrombocythemia].
Burkhardt R; Kronseder A
Fortschr Med; 1977 May; 95(19):1261-6. PubMed ID: 863367
[TBL] [Abstract][Full Text] [Related]
30. Abnormalities of megakaryocytes in myelitis and chronic myeloproliferative diseases.
Thiele J; Holgado S; Choritz H; Georgii A
Virchows Arch B Cell Pathol Incl Mol Pathol; 1982; 41(1-2):67-81. PubMed ID: 6134385
[TBL] [Abstract][Full Text] [Related]
31. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609
[TBL] [Abstract][Full Text] [Related]
32. Megakaryocytes and platelets in myeloproliferative disorders.
Briere J; Kiladjian JJ; Peynaud-Debayle E
Baillieres Clin Haematol; 1997 Feb; 10(1):65-88. PubMed ID: 9154316
[TBL] [Abstract][Full Text] [Related]
33. Megakaryocyte precursors (pro- and megakaryoblasts) in bone marrow tissue from patients with reactive thrombocytosis, polycythemia vera and primary (essential) thrombocythemia. An immunomorphometric study.
Thiele J; Wagner S; Degel C; Dienemann D; Wienhold S; Zankovich R; Fischer R; Stein H
Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 58(4):295-302. PubMed ID: 1970693
[TBL] [Abstract][Full Text] [Related]
34. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
[TBL] [Abstract][Full Text] [Related]
35. [Clinical characterization of essential thrombocythemia in comparison with other myeloproliferative diseases and reactive thrombocytoses].
Jahn M; Zönnchen B; Köpcke W; Hehlmann R
Klin Wochenschr; 1988 Mar; 66(5):190-8. PubMed ID: 3163063
[TBL] [Abstract][Full Text] [Related]
36. Light and electron microscopic studies of the bone marrow and blood cells in chronic panmyelosis including polycythemia vera and primary thrombocythemia.
Nagai K; Kamata Y; Kimura M; Chiba Y
Acta Pathol Jpn; 1975 Sep; 25(5):517-37. PubMed ID: 1199726
[TBL] [Abstract][Full Text] [Related]
37. Megakaryocytic features useful for the diagnosis of myeloproliferative disorders can be obtained by a novel unsupervised software analysis.
Tripodo C; Valenti C; Ballarò B; Rudzki Z; Tegolo D; Di Gesù V; Florena AM; Franco V
Histol Histopathol; 2006 Aug; 21(8):813-21. PubMed ID: 16691533
[TBL] [Abstract][Full Text] [Related]
38. Anagrelide-induced bone marrow changes during therapy of chronic myeloproliferative disorders with thrombocytosis. an immunohistochemical and morphometric study of sequential trephine biopsies.
Thiele J; Kvasnicka HM; Fuchs N; Brunnbauer K; Volkwein N; Schmitt-Graeff A
Haematologica; 2003 Oct; 88(10):1130-8. PubMed ID: 14555309
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of the frequency of JAK2 (V617F) mutation in different myeloproliferative disorders in Egyptian patients.
Ebid GT; Ghareeb M; Salaheldin O; Kamel MM
Int J Clin Exp Pathol; 2015; 8(9):11555-9. PubMed ID: 26617890
[TBL] [Abstract][Full Text] [Related]
40. Chronic myeloproliferative diseases on a pathologist's desk--a dilemma of distinct entities versus a clinico-pathologic continuum. A descriptive study based on a material from the Polish population.
Rudzki Z; Papla B; Stachura J
Pol J Pathol; 2004; 55(1):13-23. PubMed ID: 15195702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
